scorecardresearch
Add as a preferred source on Google
Thursday, April 30, 2026
TopicCorbevax

Topic: Corbevax

DCGI approval in, but here’s why you can’t choose Corbevax as your booster just yet

Corbevax was, over the weekend, approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India.

Drug authority clears Covaxin, Corbevax for children aged 5 to 12

DGCI also allowed emergency use of Zycov-D (Zydus Cadila vaccine) for children above 12 years.

Cleared Corbevax for ages 12-14 based on interim safety & immune response data, govt tells LS

Govt was responding to question on availability of safety & efficacy data for Corbevax, and whether it had been peer-reviewed. It sidestepped queries on efficacy & peer-review.

Corbevax is India’s ‘lowest priced vaccine’, saves exchequer Rs 1500 cr, Biological E says

Hyderabad-based Biological E has priced its vaccine at Rs 990 in the private market. For the government, however, the vaccine is at just Rs 145, making it very affordable.

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

5 months after nod, ZyCov-D set for rollout in 7 states. Bihar starts getting 1st set of shots

It will be used in six other states too. Corbevax of Biological E is also expected to start coming in this month. No decision so far on the government procuring Covovax.

Corbevax, a new patent-free Covid vaccine, is an important step to end pandemic

Corbevax was developed with global vaccine access in mind. The goal was to make a low-cost, easy-to-produce and -transport vaccine.

What it will take to vaccinate the world against Covid

A Q&A with vaccine scientist Peter Hotez, author of 'Preventing the Next Pandemic', on developing a low-cost Covid vaccine, and why Omicron won’t be the end of the pandemic.

Corbevax maker says ‘too much dependence on MNCs, focus on new tech’ behind vaccine inequity

Corbevax co-developer Dr Peter Hotez says the vaccine will 'make up for lost time' in race to immunise millions and its patent was waived in the spirit of 'decolonisation'.

How Corbevax and Covovax, the two vaccines newly approved in India, fight Covid

India granted emergency-use authorisation to two new Covid vaccines, Corbevax and Covovax, this week. Both use proteins of the coronavirus to induce an immune response.

On Camera

New promo video by PLA Navy is a teaser of China’s deep blue capabilities

Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.